comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 23:43:31 - browse：545

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Readout Newsletter: XBI biotech index, Akero Therapeutics

explore

WSS

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Scientists inch closer to single

Mitch McConnell episode has important public health takeaway

Why Sanofi got shellacked over its spinoff

Chimpanzees, like humans and whales, get menopause: Study

Micronoma's microbiome cancer diagnostic approach under fire

hotspot

comprehensive

leisure time

Medicare details structure of new drug price negotiation program

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

The high cost of giving birth even with insurance

EQRx, failed developer of low

The high cost of giving birth even with insurance

The high personal cost of affirmative action for Black doctors

Medicare proposal to cover medical devices draws a mixed reaction

Cassava reveals details — and problems — with Alzheimer's study

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cassava reveals details — and problems — with Alzheimer's study

explore

What the US credit downgrade means for the economy, your finances

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Adults seen as increasingly susceptible to measles

Hospitals warn Medicare's drug payment fix is ‘unlawful’

NIH launches clinical trials and new research office for long Covid

Paying for Covid pills will soon shift to insurers

explore

leisure time

Wikipedia

focus